This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma Gets USFDA Nod for Generic Ravicti to Treat Urea Cycle DisordersAurobindo Pharma Gets USFDA Nod for Generic Ravicti to Treat Urea Cycle Disorders
Drug Addiction Pushes BPharm Student into Theft Spree, Held in ChhattisgarhDrug Addiction Pushes BPharm Student into Theft Spree, Held in Chhattisgarh
Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss EntryRoche Restarts Phase III Trial for Elevidys to Secure EMA Approval
OpenAI Unveils GPT-Rosalind, Expands AI Push into Biotech and Pharma R&DOpenAI Unveils GPT-Rosalind, Expands AI Push into Biotech and Pharma R&D
NPPA Cannot Fix Prices for Non-Scheduled Formulations Under DPCO: Bombay HCNPPA Cannot Fix Prices for Non-Scheduled Formulations Under DPCO: Bombay HC
DCGI Pushes Reforms, Drug Approvals Now Within 150 DaysDCGI Pushes Reforms, Drug Approvals Now Within 150 Days
Rubicon Research Acquires 85% Stake in Arinna for Rs 176 CrRubicon Research Acquires 85% Stake in Arinna for Rs 176 Cr, Enters CNS Market
Hetero Targets 1.5 Million Semaglutide Pens, Eyes 75+ MarketsHetero Targets 1.5 Million Semaglutide Pens, Eyes 75+ Markets
USFDA to Review Peptide Compounding Ban, Advisory Panel Meet Set for JulyUSFDA to Review Peptide Compounding Ban, Advisory Panel Meet Set for July
US, Global Fund Scale Up Rollout of Lenacapavir Across 20+ CountriesUS, Global Fund Scale Up Rollout of Lenacapavir Across 20+ Countries
Dr Reddys Russia Arm Faces Rs 11.4 Million VAT PenaltyDr Reddy's Russia Arm Faces Rs 11.4 Million VAT Penalty
Keytruda Black Market Racket Exposed: Fake Cancer Drugs Sold Using Refilled VialsKeytruda Black Market Racket Exposed: Fake Cancer Drugs Sold Using Refilled Vials
X